LifeArc collaboration helps to advance a potential new cancer drug towards the clinic

Making our unique ULK inhibitors available as tools for the academic community has helped to reignite interest…

Exploring new approaches to drug discovery

LifeArc’s scientists have been working on a fresh approach to drug discovery, using a parallel high-throughput application…

Developing the next generation of technology transfer specialists

Technology transfer is a highly trained and multidisciplinary scientific endeavour, providing the crucial link between academic research…

Rising to the challenge of COVID-19

While the development of COVID-19 vaccines has garnered much attention, scientists have also been looking at repurposed…

Collaboration leads to promising new approach for Alzheimer’s disease

A team from LifeArc and Göttingen University has developed a new approach to intervene in early-stage treatment…

How to kill a virus: LifeArc’s role in shaping the UK’s COVID-19 response

In 2020 the UK Government, supported by UK Research and Innovation and the National Institute for Health…

LifeArc supports MRC spin-out to Series A funding

Our technology transfer team has helped the Medical Research Council (MRC), a founder in PepGen, to advance…

LifeArc scientists play pivotal role in the search for a Covid-19 antibody therapy

While much attention in the race for treatments for Covid-19 has been on the development of new…

Virtual Reality technology for small molecular drug discovery

A project by an industrial placement student led to Virtual Reality becoming a powerful tool for drug…